-
51.
公开(公告)号:BG65563B1
公开(公告)日:2008-12-30
申请号:BG10602001
申请日:2001-10-16
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/00 , C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653
Abstract: The invention relates to compounds, which inhibit the IMPDH enzyme, as well as to pharmaceutical compositions comprising such compounds. The compounds and the pharmaceutical compositions are used for inhibiting IMPDH-mediated processes; therefore they can be used for prevention and treatment of IMPDH-related troubles.
-
公开(公告)号:PT1341769E
公开(公告)日:2007-12-31
申请号:PT01994269
申请日:2001-12-12
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , GRILLOT ANNE-LAURE , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/30 , C07D235/32 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
-
公开(公告)号:DE60131015D1
公开(公告)日:2007-11-29
申请号:DE60131015
申请日:2001-12-12
Applicant: VERTEX PHARMA
Inventor: GRILLOT ANNE-LAURE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/30 , C07D235/32 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
Abstract: The present invention relates to compounds of the formula I or a pharmaceutically acceptable derivative thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention also relates to methods for treating bacterial infections in mammals. The present invention also relates to methods for decreasing bacterial quantity in a biological sample.
-
公开(公告)号:OA11848A
公开(公告)日:2006-03-08
申请号:OA1200100235
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: BADIA MICHAEL , BETHIEL SCOTT , SAUNDERS JEFFREY , STAMOS DEAN , TRUDEAU MARTIN
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07D275/34
Abstract: The present invention relates to compounds which inhibit JMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting JMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of I1VIPDH using the compounds of this invention and related compounds.
-
公开(公告)号:DE60103974T2
公开(公告)日:2005-06-30
申请号:DE60103974
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
公开(公告)号:HK1061851A1
公开(公告)日:2004-10-08
申请号:HK04104843
申请日:2004-07-06
Applicant: VERTEX PHARMA
Inventor: GRILLOT ANNELAURE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D20060101 , C07D235/32 , A01P20060101 , A61K20060101 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D235/30 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
Abstract: The present invention relates to compounds of the formula I or a pharmaceutically acceptable derivative thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention also relates to methods for treating bacterial infections in mammals. The present invention also relates to methods for decreasing bacterial quantity in a biological sample.
-
公开(公告)号:DE60103974D1
公开(公告)日:2004-07-29
申请号:DE60103974
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
公开(公告)号:AT269701T
公开(公告)日:2004-07-15
申请号:AT01903077
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
公开(公告)号:NZ514540A
公开(公告)日:2003-11-28
申请号:NZ51454000
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , C07C275/34
Abstract: A phenyl derivative has the formula (A) wherein: each of R1 and R2 is independently hydrogen, -CF3, alkyl, alkenyl, alkynyl, alkyl-R7, alkenyl-R7, alkynyl-R7 or -R7, provided at least one of R1 or R2 is alkyl-R7, alkenyl-R7, alkynyl-R7 or -R7; wherein up to 4 hydrogen atoms in any of the alkyl, alkenyl or alkynyl are optionally replaced by R3, or one or both of R1 or R2 are optionally esterified to form a prodrug or R1 and R2 are alternatively taken together to form tetrahydrofuranyl, when R9 is hydrogen, (R)-methyl, (R)- ethyl or (R)-hydroxymethyl, one hydrogen atom in the tetrahydrofuran is replaced by -OR6 or -R7, and when R9 is (S)- methyl, (S)-ethyl or (S)-hydroxymethyl, one hydrogen atom in the tetrahydrofuran is optionally replaced by -OR6 or -R7 or when R9 is hydrogen, (R)-methyl, (R)-ethyl or (R)- hydroxymethyl and each of R1 and R2 are independently hydrogen, unsubstituted alkyl, or unsubstituted alkenyl or alkynyl, then the portion of the compound represented by - CH(R1)R2 is a C5-12 alkyl, alkenyl or alkynyl; each R3 is independently halo, CN, -OR4, or -N(R5)2; R4, R5, R6 and R8 are as defined in the specification, each R7 is a monocyclic or bicyclic ring system wherein each ring system comprises 3 to 7 ring atoms independently selected from C, N, O and S, no more than 4 ring atoms are selected from N, O or S, any CH2 is optionally replaced with C (O) and any S is optionally replaced with S(O) or S(O)2; R9 is hydrogen, (R)-methyl, (S)-methyl, (R)-ethyl, (S)- ethyl, (R)-hydroxymethyl or (S)-hydroxymethyl; R10 is -C=N or 5-oxazolyl, and R11 is halo, -O-alkyl, or -O-alkenyl or -O-alkynyl. The compounds are useful for treating or preventing an inosine-5'-monophosphate dehydrogenase disease or condition.
-
公开(公告)号:BR0107713A
公开(公告)日:2002-11-19
申请号:BR0107713
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
-
-
-
-
-
-
-
-